| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.34 | 3e-09 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-05 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.21 | 3e-05 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.55 | 4e-05 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-05 |